Prognostic significance of p53 mutations in colon cancer at the population level

No abstract is available for this paper.

• Publication year

  2002

• Venue

  International Journal of Cancer

• Publication date

  2002-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.10405PMID 11992552
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer.

  2001cited by this paper
• Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level.

  2001cited by this paper
• p53 Gene Mutation, Microsatellite Instability and Adjuvant Chemotherapy: Impact on Survival of 388 Patients with Dukes’ C Colon Carcinoma

  2000cited by this paper
• Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumour site, stage, adjuvant chemotherapy and type of mutation.

  2000cited by this paper
• Relationship of Ki-ras mutations in colon cancers to tumor location, stage, and survival: a population-based study.

  2000cited by this paper
• Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.

  2000cited by this paper
• p53 tumor suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinoma

  2000cited by this paper
• Considerations in adding mutation detection services to a sequencing core facility.

  1999cited by this paper
• Prognostic value of p53 genetic changes in colorectal cancer.

  1999cited by this paper
• Considerations in adding mutation detection services to a sequencing core facility.

  1999cited by this paper
• Evaluation of multiple bio‐pathological factors in colorectal adenocarcinomas: Independent prognostic role of p53 and bcl‐2

  1999cited by this paper
• p53 point mutation and survival in colorectal cancer patients: effect of disease dissemination and tumour location.

  1999cited by this paper
• Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.

  1998cited by this paper
• TP53 and long-term prognosis in colorectal cancer: mutations in the L3 zinc-binding domain predict poor survival.

  1998cited by this paper
• Alleles of APC modulate the frequency and classes of mutations that lead to colon polyps

  1998cited by this paper
• Somatic mutations, acetylator status, and prognosis in colorectal cancer

  1998cited by this paper
• Energy balance and colon cancer--beyond physical activity.

  1997cited by this paper
• p53 alterations are associated with improved prognosis in distal colonic carcinomas.

  1997cited by this paper
• Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma.

  1996cited by this paper
• PROGNOSTIC SIGNIFICANCE OF p53 ABNORMALITIES IN COLORECTAL CARCINOMA DETECTED BY PCR–SSCP AND IMMUNOHISTOCHEMICAL ANALYSIS

  1996cited by this paper
• p53 nuclear protein overexpression in colorectal cancer: a dominant predictor of survival in patients with advanced hepatic metastases.

  1996cited by this paper
• p53 point mutation and survival in colorectal cancer patients.

  1995cited by this paper
• Prognostic value of TP53 and K-ras-2 mutational analysis in stage III carcinoma of the colon.

  1995cited by this paper
• Evaluation of p53 protein expression as a marker for long-term prognosis in colorectal carcinoma.

  1995cited by this paper
• p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma.

  1995cited by this paper
• The common molecular genetic alterations in Dukes' B and C colorectal carcinomas are not short‐term prognostic indicators of survival

  1994cited by this paper
• Prognostic factors of colorectal cancer: K‐ras mutation, overexpression of the p53 protein, and cell proliferative activity

  1994cited by this paper
• Mutations of Ki-ras and p53 genes in colorectal cancer and their prognostic significance.

  1994cited by this paper
• Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

  1994cited by this paper
• Association of p53 mutations with short survival in colorectal cancer.

  1994cited by this paper
• Overexpression of p53 and long-term survival in colon carcinoma.

  1994cited by this paper
• p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer, and its prognostic significance.

  1993cited by this paper
• Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer.

  1993cited by this paper
• Prognostic significance of p53 overexpression in gastric and colorectal carcinoma.

  1992cited by this paper
• Increased p53 protein content of colorectal tumours correlates with poor survival.

  1992cited by this paper
• p53 in colorectal cancer: clinicopathological correlation and prognostic significance.

  1991cited by this paper
• p53 mutations in human cancers.

  1991cited by this paper
• Carcinoma

  1906cited by this paper

• P53 Function Status Correlates With Overall Survival in Patients With Resected Pancreatic Cancer

  2025influential citation
• The prevalence of TP53, APC, and PIK3CA gene mutations in colorectal cancer patients: A Systematic Review and Meta-analysis

  2025cites this paper
• TP53 mutation heterogeneity reveals distinct prognoses in mantle cell lymphoma

  2024cites this paper
• Patterns of Somatic Variants in Colorectal Adenoma and Carcinoma Tissue and Matched Plasma Samples from the Hungarian Oncogenome Program

  2023cites this paper
• DNA Methyltransferase 3A: a Significant Target for the Discovery of Inhibitors as Potent Anticancer Drugs.

  2023cites this paper
• Synthesis of copper-reduced graphene oxide nanomaterials using glucose and study of its antibacterial and anticancer activities

  2023cites this paper
• Amyloid-like p53 as prognostic biomarker in serous ovarian cancer—a study of the OVCAD consortium

  2023cites this paper
• BRAF-mutated colorectal adenocarcinomas: pathological heterogeneity and clinical implications.

  2022cites this paper
• Cross-Talk between p53 and Wnt Signaling in Cancer

  2022cites this paper
• Association of β-Catenin, APC, SMAD3/4, Tp53, and Cyclin D1 Genes in Colorectal Cancer: A Systematic Review and Meta-Analysis

  2022cites this paper
• High Tumor Mutation Burden and DNA Repair Gene Mutations are Associated with Primary Resistance to Crizotinib in ALK-Rearranged Lung Cancer

  2021cites this paper
• OTT_A_325443 4809..4817

  2021cites this paper
• Expression of K-Ras, p53 and Ki-67 in Precancerous and Cancerous Lesions of Colorectum

  2020cites this paper
• In-gel digestion coupled with mass spectrometry (GeLC-MS/MS)-based salivary proteomic profiling of canine oral tumors

  2020cites this paper
• TP53 DNA Binding Domain Mutations Predict Progression-Free Survival of Bevacizumab Therapy in Metastatic Colorectal Cancer

  2019cites this paper
• Progress in Microbes and Molecular Biology

  2019cites this paper
• Five P53 SNPs Involved in Low Rectal Cancer Risk and Prognosis in a Chinese Population

  2019cites this paper
• How the BRAF V600E Mutation Defines a Distinct Subgroup of Colorectal Cancer: Molecular and Clinical Implications

  2018cites this paper
• Mutation analysis of adenomas and carcinomas of the colon: Early and late drivers

  2018cites this paper
• CHIP promotes autophagy‐mediated degradation of aggregating mutant p53 in hypoxic conditions

  2018cites this paper
• How the BRAF V 600 E Mutation Defines a Distinct Subgroup of Colorectal Cancer : Molecular and Clinical Implications

  2018cites this paper
• PHD in EXPERIMENTAL AND TRANSLATIONAL MEDICINE COORDINATOR: PROF. DANIELA NEGRINI CLINICO-PATHOLOGIC, HISTOPHENOTYPIC, MOLECULAR AND PROGNOSTIC CHARACTERIZATION OF SMALL BOWEL CARCINOMAS ASSOCIATED WITH CELIAC DISEASE OR CROHN’S DISEASE

  2018cites this paper
• An expression of p53 marker in colorectal cancer with histopathological correlation

  2017cites this paper
• Oxypeucedanin hydrate monoace- tate isolated from Angelica dahurica induces apoptosis in Caco-2 colon carcinoma cells through the media- tion of PI3K-signalling pathway and inhibition of cancer cell migration

  2017cites this paper
• Insights into the Effect of the G245S Single Point Mutation on the Structure of p53 and the Binding of the Protein to DNA

  2017cites this paper
• Small Bowel Carcinomas in Coeliac or Crohn’s Disease: Clinico-pathological, Molecular, and Prognostic Features. A Study From the Small Bowel Cancer Italian Consortium

  2017cites this paper
• Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing–based cohort study

  2017cites this paper
• Molecular Characterization of Somatic Alterations in Dukes’ B and C Colorectal Cancers by Targeted Sequencing

  2017influential citation
• Mutant p53 upregulates alpha-1 antitrypsin expression and promotes invasion in lung cancer

  2017cites this paper
• Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53.

  2017cites this paper
• Bioinformatics analysis of RNA-seq data revealed critical genes in colon adenocarcinoma.

  2017cites this paper
• Heat Shock Protein 70s as Potential Molecular Targets for Colon Cancer Therapeutics.

  2016cites this paper
• Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern.

  2016cites this paper
• Expression Pattern and Clinicopathological Relevance of the Indoleamine 2,3-Dioxygenase 1/Tryptophan 2,3-Dioxygenase Protein in Colorectal Cancer

  2016cites this paper
• Characterization and functional analysis of mutant p53 secretome in human cancer

  2016cites this paper
• Precision Surgery and Surgical Spectroscopy

  2016cites this paper
• Combined treatment with vitamin C and sulindac synergistically induces p53- and ROS-dependent apoptosis in human colon cancer cells.

  2016cites this paper
• The iKnife: real time Intra-operative tissue diagnostics using rapid evaporative ionisation mass spectrometry

  2015cites this paper
• Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancer.

  2015cites this paper
• Improved survival among colon cancer patients with increased differentially expressed pathways

  2015cites this paper
• Does anti-p53 antibody status predict for clinical outcomes in metastatic colorectal cancer patients treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chemotherapy?

  2015cites this paper
• VEGFA, FLT1, KDR and colorectal cancer: Assessment of disease risk, tumor molecular phenotype, and survival

  2014cites this paper
• An analysis of genetic factors related to risk of inflammatory bowel disease and colon cancer.

  2014cites this paper
• p53: its mutations and their impact on transcription.

  2014cites this paper
• White Opaque Substance Visualized Using Magnifying Endoscopy with Narrow-Band Imaging in Colorectal Epithelial Neoplasms

  2014cites this paper
• MicroRNAs 146a and 147b Biomarkers for Colorectal Tumor's Localization

  2014cites this paper
• Implication of K-ras and p53 in colorectal cancer carcinogenesis in Tunisian population cohort

  2014cites this paper
• Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among Indians

  2013cites this paper
• Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study

  2013cites this paper
• Restoration of wild-type p53 in drug-resistant mouse breast cancer cells leads to differential gene expression, but is not sufficient to overcome the malignant phenotype

  2013cites this paper
• TERT's role in colorectal carcinogenesis

  2013cites this paper
• Interleukin genes and associations with colon and rectal cancer risk and overall survival

  2013cites this paper
• Cladosporol a stimulates G1‐phase arrest of the cell cycle by up‐regulation of p21waf1/cip1 expression in human colon carcinoma HT‐29 cells

  2013cites this paper
• Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia.

  2013cites this paper
• An Alternative Pathway in Colorectal Carcinogenesis Based on the Mismatch Repair System and p53 Expression in Korean Patients with Sporadic Colorectal Cancer

  2013cites this paper
• Ubiquitin ligase A20 regulates p53 protein in human colon epithelial cells

  2013cites this paper
• CIZ1 regulates the proliferation, cycle distribution and colony formation of RKO human colorectal cancer cells.

  2013cites this paper
• Potential Role of KRAS and Other Mutations in the Adjuvant Therapy of Colorectal Cancer

  2012cites this paper
• Genetic variation in bone morphogenetic protein and colon and rectal cancer

  2012cites this paper
• p53 mutation is common in microsatellite stable, BRAF mutant colorectal cancers

  2012cites this paper
• Relationship Between MDM2 and p53 Alterations in Colorectal Cancer and Their Involvement and Prognostic Value in the Tunisian Population

  2012cites this paper
• Genetic variability in IL23R and risk of colorectal adenoma and colorectal cancer.

  2012cites this paper
• MAP kinase genes and colon and rectal cancer.

  2012cites this paper
• Identification and functional analysis of slowly cycling cells in colorectal cancer

  2012cites this paper
• Combined metallothioneins and p53 proteins expression as a prognostic marker in patients with Dukes stage B and C colorectal cancer.

  2012cites this paper
• Glutathione peroxidase tagSNPs: Associations with rectal cancer but not with colon cancer

  2012cites this paper
• Mutations and polymorphisms in TP53 gene--an overview on the role in colorectal cancer.

  2012cites this paper
• Genetic variation in RPS6KA1, RPS6KA2, RPS6KB1, RPS6KB2, and PDK1 and risk of colon or rectal cancer.

  2011cites this paper
• Predictive and Prognostic Factors in Colorectal Cancer: A Personalized Approach

  2011cites this paper
• Genetic variability in EGFR, Src and HER2 and risk of colorectal adenoma and cancer.

  2011cites this paper
• Variation in the CYP19A1 gene and risk of colon and rectal cancer

  2011cites this paper
• Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival.

  2011cites this paper
• High Expression of Testes-Specific Protease 50 Is Associated with Poor Prognosis in Colorectal Carcinoma

  2011cites this paper
• Gain of function of mutant p53 by coaggregation with multiple tumor suppressors.

  2011cites this paper
• Genetic variation in C‐reactive protein in relation to colon and rectal cancer risk and survival

  2011cites this paper
• Cladosporol A Stimulates G 1-Phase Arrest of the Cell Cycle by Up-Regulation of p 21 waf 1 / cip 1 Expression in Human Colon Carcinoma HT-29 Cells

  2011cites this paper
• Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and riskof colon and rectal cancer: additional support for a TGF-β-signaling pathway.

  2011cites this paper
• Adjuvant Treatment and Predictors of Response in Colon Cancer

  2011cites this paper
• Genetic variation in the transforming growth factor‐β signaling pathway and survival after diagnosis with colon and rectal cancer

  2011cites this paper
• The impact of a high-frequency microsatellite instability phenotype on the tumor location-related genetic differences in colorectal cancer.

  2010cites this paper
• Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin.

  2010cites this paper
• Genetic Variation in the TGF-β Signaling Pathway and Colon and Rectal Cancer Risk

  2010cites this paper
• Polymorphism of Increased Risk of Colon Cancer Associated with a Genetic

  2010cites this paper
• Esculetin inhibits cell proliferation through the Ras/ERK1/2 pathway in human colon cancer cells.

  2010cites this paper
• c-Jun N-terminal kinase 1 is required for cordycepin-mediated induction of G2/M cell-cycle arrest via p21WAF1 expression in human colon cancer cells.

  2010cites this paper
• Location-related differences in sporadic microsatellite unstable colorectal cancer.

  2010cites this paper
• The prognostic value of c‐Kit, K‐ras codon 12, and p53 codon 72 mutations in Egyptian patients with stage II colorectal cancer

  2010cites this paper
• Increased risk of colon cancer associated with a genetic polymorphism of SMAD7.

  2010cites this paper
• Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.

  2010cites this paper
• Molecular Gate Keepers Succumb to Gene Aberrations in Colorectal Cancer in Kashmiri Population, Revealing a High Incidence Area

  2009influential citation
• Distinct pattern of mutations of conserved regions of TP53 in colorectal cancer patients in the Kashmir population: an emerging high-risk area

  2009cites this paper
• Inhibitory effects of the ethanol extract of Gleditsia sinensis thorns on human colon cancer HCT116 cells in vitro and in vivo.

  2009cites this paper
• Microsatellite instability and survival in rectal cancer

  2009cites this paper
• P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.

  2009cites this paper
• Oncogenetic tree model of somatic mutations and DNA methylation in colon tumors

  2009cites this paper
• Age-related methylation in normal colon mucosa differs between the proximal and distal colon in patients who underwent colonoscopy.

  2008cites this paper
• P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K‐ras mutations

  2008cites this paper
• Expression of P53, P27 and KI‐67 in colorectal cancer patients of various ethnic origins: Clinical and tissue microarray based analysis

  2008cites this paper
• Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.

  2007cites this paper
• Inhibition of Fas expression by RNAi modulates 5-fluorouracil-induced apoptosis in HCT116 cells expressing wild-type p53.

  2007cites this paper